Australian IVD Remains Strong in a Constellation of Asian Markets

Australian IVD Remains Strong in a Constellation of Asian Markets

With universal healthcare and high patient utilization of a modern healthcare system, Australia represents a premier in vitro diagnostics (IVD) market in the Asia-Pacific with excellent per capita IVD spending on par with Japan and superior to markets in developed countries such as Singapore and Korea. Australia also projects to outperform the IVD markets in either Japan or Singapore in terms of growth.

Approximately half of every dollar spent on clinical testing or pathology services in Austr...